Clearside Biomedical, Inc. Announces Purchase of iScience Patent Portfolio for Suprachoroidal Space Drug Delivery

ALPHARETTA, Ga.--(BUSINESS WIRE)--Clearside Biomedical, which develops drug therapies to treat eye diseases, announces acquisition of iScience Interventional Corp.’s patent portfolio covering drug delivery to the suprachoroidal space.